Modulation of cholesterol in midlife affords cognitive advantage during ageing - a role for altered redox balance

M. Cristina Polidori, Ludger Pientka, Gereon Nelles, Helen R. Griffiths

Research output: Contribution to journalArticlepeer-review


General practitioners, geriatricians, neurologists and health care professionals all over the world will be facing by 2040 the diagnostic, therapeutic and socioeconomic challenges of over 80 million people with dementia. Dementia is one of the most common diseases in the elderly which drastically affects daily life and everyday personal activities, is often associated with behavioural symptoms, personality change and numerous clinical complications and increases the risk for urinary incontinence, hip fracture, and - most markedly - the dependence on nursing care. The costs of care for patients with dementia are therefore immense. Serum cholesterol levels above 6.5 mmol/L are known to be associated with an increased RR of 1.5 and 2.1 to develop Alzheimeŕs disease, the most common form of dementia, and a reduction of serum cholesterol in midlife is associated with a lowered dementia risk. The aim of this work is to critically discuss some of the main results reported recently in the literature in this respect and to provide the pathophysiological rationale for the control of dyslipidemia in the prevention of dementia onset and progression.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalInternational Journal of Clinical and Experimental Medicine
Issue number2
Early online date20 Apr 2010
Publication statusPublished - 18 Aug 2010


  • ageing
  • cholesterol
  • cognition
  • LDL
  • oxidation


Dive into the research topics of 'Modulation of cholesterol in midlife affords cognitive advantage during ageing - a role for altered redox balance'. Together they form a unique fingerprint.

Cite this